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Abstract Purpose: To investigate
whether angiopoietin-2, von Wille-
brand factor (VWF) and angiopoietin-
1 relate to surrogate indicators of
vascular permeability, pulmonary
dysfunction and intensive care unit
(ICU) mortality throughout the course
of septic shock. Methods: In 50
consecutive mechanically ventilated
septic shock patients, plasma angio-
poietin-2, VWF and angiopoietin-1
levels and ﬂuid balance, partial pres-
sure of oxygen/inspiratory oxygen
fraction and the oxygenation index as
indicators of vascular permeability
and pulmonary dysfunction, respec-
tively, were measured until day 28.
Results: Angiopoietin-2 positively
related to the ﬂuid balance and pul-
monary dysfunction, was higher in
non-survivors than in survivors and
independently predicted non-survival
throughout the course of septic shock.
VWF inversely related to the ﬂuid
balance and pulmonary dysfunction
throughout the course of septic shock,
was comparable between survivors
and non-survivors and predicted non-
survival on day 0 only. Angiopoietin-
1 positively related to pulmonary
dysfunction throughout the course,
but did not differ between survivors
and non-survivors. Conclusions: In
contrast to VWF, plasma angiopoie-
tin-2 positively relates to ﬂuid
balance, pulmonary dysfunction and
mortality throughout the course of
septic shock, in line with a suggested
mediator role of the protein.
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Introduction
Excessive and sustained activation of the endothelium
resulting in increased vascular permeability is a crucial
process during sepsis [1, 2]. In the lung, the loss of plasma
ﬂuid into the interstitial space leads to pulmonary
oedema, injury and dysfunction associated with acute
lung injury (ALI) and acute respiratory distress syndrome
(ARDS) [1, 3]. Several clinical studies demonstrated that
circulating levels of angiopoietin-2 (Ang-2) are elevated
at the onset of critical illness in septic and non-septic
patients with or at risk for ALI/ARDS, relate to vascular
permeability and pulmonary dysfunction and are associ-
ated with intensive care unit (ICU) mortality [4–12]. It is
not surprising that Ang-2 is a marker of those processes,
since pre-formed Ang-2 can be released from the endo-
thelial Weibel-Palade bodies during endothelial activation
[13]. Another well-known marker of endothelial activa-
tion and dysfunction is von Willebrand factor (VWF),
which is a major constituent of the Weibel-Palade body
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levels are simultaneously enhanced in the plasma of ALI/
ARDS or sepsis patients on admission to the ICU or onset
of sepsis, suggesting that they are released together upon
activation of the endothelium [12]. This may explain why
both Ang-2 and VWF levels are associated with vascular
permeability and pulmonary dysfunction [4–6, 8, 11, 12],
even though VWF may not be directly involved in per-
meability [15, 16].
Experimental studies demonstrated that angiopoietin-1
(Ang-1) and Ang-2 bind to the endothelial Tie2 receptor
[17–19]. Ang-1-induced activation of the Tie2 receptor
results in vascular stabilisation [20–22]. Ang-2 provokes
pulmonary inﬂammation and vascular leakage partly
because of inhibition of the stabilising effect of Ang-1 by
preventing Ang-1 from binding the Tie2 receptor [4, 5, 8,
10–12, 23, 24]. These experimental data together with
clinical observations [4, 6, 7, 9, 11, 12] suggest that Ang-
2 is not only a marker, but also a direct mediator in the
pathogenesis of vascular permeability, pulmonary injury
and dysfunction. This idea would be further reinforced if
the relation between Ang-2, vascular permeability and
pulmonary dysfunction persists throughout the course of
critical illness in a homogeneous population of septic
shock patients, more than VWF and Ang-1 levels. Up till
now, the course and clinical correlates of Ang-2 have not
been studied, and the predictive value of changes in Ang-
2 during the course of septic shock for mortality is
unknown. It has been hypothesised that the levels typi-
cally decrease in septic survivors and increase in septic
patients that do not survive [5]. Only one study reported
on the course of Ang-2 levels in multi-trauma patients [9],
but clinical correlates were not studied.
The aims of our study were (1) to investigate whether
Ang-2, VWF and Ang-1 relate to surrogate indicators of
vascular permeability and pulmonary dysfunction
throughout the course of septic shock and (2) to study the
course of Ang-2, VWF and Ang-1 levels in survivors and
non-survivors and their predictive value for ICU mortal-
ity. Therefore, we measured plasma levels of Ang-2,
VWF and Ang-1, and recorded ﬂuid balance as surrogate
indicator of vascular permeability [25–28] and partial
pressure of oxygen in arterial blood/inspiratory oxygen
fraction (PaO2/FiO2), oxygenation index [29], pulmonary
compliance and ventilator-dependency [30] as surrogate
indicators of pulmonary dysfunction, respectively,
throughout the course of septic shock.
Materials and methods
The local ethics committee approved this observational
study and waived the need for informed consent. Fifty
consecutive mechanically ventilated critically ill patients
with community or ICU-acquired septic shock admitted to
the ICU of the Radboud University Medical Centre (Nij-
megen, The Netherlands) between January 2005 and
September 2007 were included within 12 h after meeting
septic shock criteria. Sepsis was deﬁned by two or more
of the following: abnormal body temperature (\36 or
[38.5C), tachycardia ([90/min), tachypnea [[20/min
or partial pressure of CO2 in arterial blood (PaCO2)
\32 mmHg], abnormal white blood cell counts (\4o r
[12 9 10
9/l) and a microbiologically proven or clinically
evident source of infection [29]. Septic shock was deﬁned
as sepsis complicated by acute circulatory failure charac-
terised by persistent arterial hypotension unexplained by
other causes [31]. Hypotension was deﬁned by systolic
arterial pressure \90 mmHg or mean arterial pressure
(MAP)\70 mmHg for at least 1 h despite adequate ﬂuid
resuscitation or requirement of vasopressor support to
maintain MAP [31]. ICU-acquired sepsis was deﬁned as
sepsis developing after 2 days in the ICU. The origin of
septic shock was deﬁned by clinical signs and symptoms
and positive local and/or blood cultures. Patients were
pressure-controlled or volume-controlled (after surgery)
ventilated with a Galileo (Hamilton Medical AG; Rha ¨-
zu ¨ns, Switserland) or a Servo ventilator (Maquet, Inc.;
Bridgewater, NJ). Patients with ALI/ARDS were pressure-
controlled ventilated with a tidal volume (Vt) aiming not to
exceed 8 ml/kg and resulting in an end-tidal CO2 con-
centration between 4 and 5%, using an O2–air mixture
with a FiO2 of 40% and a positive end-expiratory pressure
(PEEP) of 5 cmH2O (inspiration:expiration 1:2) or more,
when needed, guided by PaO2 ([60 mmHg). Patients were
followed until death or discharge from the hospital. The
28-day ICU mortality, total ICU mortality and hospital
mortality were recorded. Patients were treated by intensive
care physicians not involved in the study according to
institutional guidelines. Platelets were infused when the
platelet count had dropped below 10–20 9 10
9/l, possibly
as a result of diffuse intravascular coagulation, and when
there were foci with a bleeding tendency.
On the inclusion day (day 0), demographics and
clinical data were recorded including the Acute Physi-
ology and Chronic Health Evaluation (APACHE) II
score. The number of failing organs was scored. On day
0, day 7 ± 1 days, day 14 ± 2 days and day
28 ± 3 days, arterial blood samples were obtained for
determinations of pH, PaO2 and PaCO2, white blood cell
counts and creatinine. The respiratory frequency, tidal
volume (Vt), FiO2, plateau pressure (Pplat), mean airway
pressure (Pmean) and PEEP were taken from the venti-
lator. The oxygenation index, which is a measure of
oxygenation impairment for the intensity of mechanical
ventilation, was calculated from (Pmean 9 FiO2 9 100)/
PaO2 [29]. Total respiratory dynamic compliance was
calculated from Vt/(plateau pressure-PEEP). Ventilator-
free days were deﬁned as follows: ventilator-free
days = 0 if the patient dies before ICU day 28; venti-
lator-free days = 28 - x if the patient is successfully
1568weaned from mechanical ventilation within 28 days,
where x is the number of days spent on mechanical
ventilation; ventilator-free days = 0 if the patient
requires mechanical ventilation for 28 days or more [30].
Days at which a patient was ventilator-dependent were
recorded. ALI and ARDS were characterised by PaO2/
FiO2 B300 or B200 mmHg, respectively, and absence of
clinical evidence of left atrial hypertension and conges-
tive heart failure, according to the American European
Consensus Criteria [32]. Vasopressor/inotropic treatment
and body temperature were recorded. The ﬂuid balance
was calculated by dividing total ﬂuid input minus total
ﬂuid output by the pre-ICU patient weight in kilograms
[25–28]. Circulating Ang-2, VWF and Ang-1 were
measured as described in the electronic supplementary
material (ESM). The statistical analysis is described in
the ESM.
Results
Patient characteristics
Patients were grouped as ICU survivor or non-survivor
(Table 1, ESM Table 1). All ICU non-survivors, except
one (death on day 68), died before ICU day 28. Five ICU
survivors died in the hospital at a median 24 (range 2–60)
days after discharge from the ICU. ICU survivors and
non-survivors were comparable with respect to baseline
demographics and with respect to clinical characteristics,
except for APACHE II score and hospital stay, which
were higher and shorter, respectively, in non-survivors
compared to survivors. Twenty-two survivors and 14 non-
survivors suffered from ALI/ARDS (Table 1). Haemo-
dynamic, biochemical and respiratory characteristics are
reported in the ESM.
Angiopoietin and VWF levels, ﬂuid balance and
pulmonary dysfunction
Patients had higher Ang-2 and VWF levels on day 0
[median (interquartile range) 2,350 (1,400–4,280) pg/ml
and 289 (166–411)% of reference, respectively] than
controls [113 (27–287) pg/ml, P\0.001 and 93 (87–
113)% of reference, P\0.001, respectively]. Patients
had lower Ang-1 levels on day 0 [330 (114–1,020) pg/
ml] than controls [2,407 (969–3,730) pg/ml, P\0.001].
Ang-2 levels related positively to the ﬂuid balance
throughout the course of septic shock after exclusion of
one non-survivor who had extremely high Ang-2 levels
(b = 0.20, P = 0.043 in GEE, r = 0.30, P = 0.005).
Furthermore, Ang-2 levels related to indicators of pul-
monary dysfunction throughout the course of septic
shock, as demonstrated by an inverse relation with the
PaO2/FiO2 ratio (b =- 0.25, P\0.001 in GEE; r =
-0.25, P = 0.012), a positive relation with the oxy-
genation index (b = 0.37, P\0.001 in GEE; r = 0.26,
P = 0.017), a weak inverse relation with the compliance
(b =- 0.09, P = 0.004 in GEE; r =- 0.05, P = 0.645)
and a positive relation with ventilator-dependency
(P = 0.043 in GEE). In contrast, VWF inversely related
to the ﬂuid balance (b =- 0.21, P = 0.045 in GEE;
r =- 0.27, P = 0.014), positively related to the com-
pliance (b = 0.21, P = 0.011 in GEE; r = 0.17,
P = 0.134) and did not relate to the other respiratory
variables throughout the course of septic shock. Ang-1
levels did not relate to the ﬂuid balance, but related to
indicators of pulmonary dysfunction throughout the
course of septic shock, as demonstrated by an inverse
relation with the PaO2/FiO2 ratio (b =- 0.26,
P = 0.022 in GEE; r =- 0.21, P = 0.034) and a posi-
tive relation with the oxygenation index (b = 0.37,
P = 0.005 in GEE; r = 0.28, P = 0.014) throughout the
course of septic shock. The ﬂuid balance related to
indicators of pulmonary dysfunction throughout the
course of septic shock, as demonstrated by an inverse
relation with the PaO2/FiO2 ratio (b =- 0.24, P\0.001
in GEE; r =- 0.29, P = 0.006), a positive relation with
the oxygenation index (b = 0.22, P = 0.006 in GEE;
r = 0.22, P = 0.068) and an inverse relation with the
compliance (b =- 0.26, P = 0.006 in GEE; r =- 0.29,
P = 0.014).
The course of the angiopoietin and VWF levels in
survivors and non-survivors
Ang-2 levels were higher in non-survivors than in survi-
vors throughout the course of septic shock (Fig. 1). Ang-2
levels decreased in survivors from day 0 to the last ICU
day, while they did not change in non-survivors (Figs. 1,
2). The course of VWF levels differed between survivors
and non-survivors (Fig. 1), since VWF levels increased in
survivors from day 0 to the last ICU day, while they did
not change in non-survivors (Fig. 2). Ang-2 levels related
to VWF levels on day 0, but the relation was lost
throughout the course of septic shock (Fig. 3). Ang-1
levels were comparable between survivors and non-sur-
vivors (Fig. 1) and did not change from day 0 to the last
ICU day (Fig. 2). The predictive value of angiopoietin
and VWF levels for ICU mortality is described in the
ESM.
Discussion
This study demonstrates that circulating Ang-2 positively
relates to the ﬂuid balance, pulmonary dysfunction and
1569mortality throughout the course of septic shock. This is in
line with the suggested mediator role of Ang-2 in those
patients. In contrast, VWF was not positively related to
the ﬂuid balance and pulmonary dysfunction and pre-
dicted mortality only at the day of ICU admission,
suggesting that VWF plays a marker role only in the early
phase of septic shock. Indeed, circulating VWF and Ang-
2 were related at day 0, but not throughout the course of
septic shock.
Experimental data [5, 19, 23] together with several
observations in patient studies [4–9, 11, 12, 25] suggest
that Ang-2 is a mediator in the pathogenesis of pulmonary
vascular permeability and injury. This hypothesis is
reinforced by several aspects of the present study. First,
the relation between circulating Ang-2 and the ﬂuid bal-
ance or pulmonary dysfunction persisted throughout the
course of septic shock. Second, this longitudinal relation
was Ang-2-speciﬁc, since VWF, which is also considered
a marker of endothelial activation and dysfunction, did
not reﬂect a positive ﬂuid balance and pulmonary
dysfunction. Third, the relation was observed within a
relatively homogeneous group of septic patients with high
Ang-2 levels and severe vascular permeability and pul-
monary dysfunction, while previous studies focused on
heterogeneous populations [4–7, 10–12]. In those heter-
ogeneous populations, Ang-2, vascular permeability and
pulmonary dysfunction may be related due to a group
effect, because non-septic patients have low Ang-2 levels
and moderate vascular permeability or pulmonary dys-
function, while septic patients have high Ang-2 levels and
severe vascular permeability or pulmonary dysfunction.
Nevertheless, in vivo Ang-2 blocking studies are neces-
sary to formally conﬁrm the mediator role of Ang-2.
Ang-2 levels at day 0 and throughout the course had
independent predictive value for 28 day survival, in
accordance with a previous study [10], since patients with
Ang-2 levels \3,066 pg/ml had longer survival duration
than patients with Ang-2 levels C3,066 pg/ml, indepen-
dent of the APACHE II score. Nevertheless, these cutoff
values were selected post-hoc and should be validated
Table 1 Demographic and clinical characteristics of survivors and non-survivors
Survivors
(n = 35)
Non-survivors
(n = 15)
P value
Age, year 68 (21–87) 65 (30–102) 0.427
Sex, male 21 (60) 13 (87) 0.099
Surgery prior to sepsis 17 (49) 9 (60) 0.459
Source of sepsis 0.529
Pulmonary 15 (43) 9 (60)
Abdominal 15 (43) 5 (33)
Urogenital 1 (3) 0
Pressure sores 1 (3) 0
Unknown 5 (14) 2 (13)
Culture results 0.241
Blood gram - 2 (6) 1 (7)
Blood gram ? 0 2 (13)
Local
a gram - 5 (14) 3 (9)
Local
a gram ? 7 (20) 1 (7)
Leukocytes day 0, 910
9/l 11.9 (2.8–86.0) 2.7 (0.4–74.8) 0.661, 0.209
Leukocytes day 7, 910
9/l 15.6 (5.6–54.5) 11.3 (1.7–243.1)
Leukocytes day 14, 910
9/l 12.8 (7.5–33.8) 18.8 (4.1–101.0)
Temperature day 0, C 37.7 (34.4–41.2) 38.0 (34.3–40.4) 0.288, 0.600
Temperature day 7, C 37.5 (35.6–39.8) 38.2 (34.0–40.0)
Temperature day 14, C 38.1 (35.5–39.3) 38.1 (37.2–39.9)
Number of failing organs 2 (1–6) 2 (1–7) 0.425
Severity of lung injury 0.869
Non-ALI 3 (9) 1 (7)
ALI 9 (26) 3 (9)
ARDS 23 (66) 11 (73)
ICU-acquired sepsis 4 (12) 1 (6) 1.000
APACHE II score 20.5 (9.0–34.0) 22.0 (18.0–53.0) 0.014
Ventilator-free days 14 (0–27) 0 \0.001
ICU stay, days 13 (2–86) 6 (1–68) 0.056
Hospital stay, days 53 (6–146) 10 (1–83) 0.002
Variables are expressed as median (range) or as number of patients
(percentage) with P value (survivor vs. non-survivor and interaction
between day and survivor vs. non-survivor)
Non-ALI non-acute lung injury deﬁned as partial pressure of O2
in arterial blood/inspiratory O2 fraction (PaO2/FiO2)a td a y0
[300 mmHg, ALI deﬁned as PaO2/FiO2 at day 0 [200 and
B300 mmHg, ARDS acute respiratory distress syndrome deﬁned as
PaO2/FiO2 at day 0 B200 mmHg, ICU intensive care unit,
APACHE Acute Physiology And Chronic Health Evaluation
a Local when blood-culture negative
1570prospectively. It has been proposed previously that cir-
culating Ang-2 levels may better predict mortality of
critically ill patients than the APACHE II score [7, 11].
For instance, Siner et al. [11] reported that there were no
deaths among patients with Ang-2 levels less than
10,000 pg/ml, despite a predicted mortality of 16% based
on the median APACHE II score. Indeed, the combination
of Ang-2 and the APACHE II score had more predictive
value than the APACHE II score alone. In our patient
group, we did not observe a sharp increase in Ang-2
levels towards the day of death as was described for one
patient by Parikh et al. [5]. Ang-2 was continuously
higher in non-survivors compared to survivors. Interest-
ingly, Ang-2 levels in survivors, which were already
lower throughout the course, decreased from day 0 to the
last ICU day. In this light, Ang-2 levels above a certain
threshold may mediate the development of endothelial
activation and dysfunction, associated with pulmonary
dysfunction and mortality. Surprisingly, Ang-1 levels also
positively related to pulmonary dysfunction. Neverthe-
less, Ang-1 levels in our septic shock patients were still
much lower than Ang-1 levels in healthy controls
according to the literature [10, 12], suggesting that the
low Ang-1 levels did not offset the effects of high Ang-2
levels. Indeed, the Ang-2/Ang-1 ratio did not relate to the
ﬂuid balance or pulmonary dysfunction and mortality
(data not shown).
VWF levels related inversely to the ﬂuid balance and
positively to the pulmonary compliance throughout the
course of septic shock. This ﬁnding is in accordance with
studies that did not ﬁnd a predictive value for the devel-
opment of ALI/ARDS [33, 34], while other studies
reported that VWF levels at the onset of critical illness
predicted the development of ALI/ARDS and related to
pulmonary permeability [12, 35]. It is unclear how these
differences can be explained, but the predictive value of
VWF might depend on the time at which the samples
were taken during the course of sepsis or ALI/ARDS.
Indeed, VWF had predictive value for mortality early in
the course of sepsis and ALI/ARDS (day 0), as reported
by most [15, 16, 33, 35], but not all prior studies [36], but
lost its predictive value on the subsequent days. Although
VWF may thus have an important early prognostic role,
the data do not suggest a direct pathogenetic role of the
factor, in contrast to Ang-2.
In our study, increased Ang-2 and VWF levels were
related on day 0 as reported before [8, 12], suggesting that
they were released together from the endothelial Weibel-
Palade body, but not on the subsequent days. There are
several explanations for the observed loss of relation
Fig. 1 The course of angiopoietin and VWF levels in survivors and
non-survivors. Median and interquartile range of a circulating
angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor (VWF; %
of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml) in plasma
of intensive care unit (ICU) survivors (open circle) and ICU non-
survivors (ﬁlled circle) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28
are not shown because of low numbers, but are included in the
analysis. a Ang-2 levels tended to be higher in non-survivors than
in survivors throughout the course of septic shock (P = 0.199 for
survivor vs. non-survivor and P = 0.028 for interaction between
day and survivor vs. non-survivor). One non-survivor had
extremely high Ang-2 levels: day 0 125,100 pg/ml; day 1
149,000 pg/ml; day 2 114,300 pg/ml; day 4 115,550 pg/ml and
day 7 116,800 pg/ml. Therefore, the upper limit of interquartile
range at day 7 is 88,263 pg/ml. Analysis without this non-survivor
yields a P = 0.039 for survivor versus non-survivor and P = 0.016
for the interaction between day and survivor versus non-survivor. b
VWF levels did not differ between survivors and non-survivors
throughout the course of septic shock (P = 0.545 for survivor vs.
non-survivor and P = 0.218 for interaction between day and
survivor vs. non-survivor). c Ang-1 levels did not differ between
survivors and non-survivors throughout the course of septic shock
(P = 0.189 for survivor vs. non-survivor and P = 0.070 for
interaction between day and survivor vs. non-survivor)
a
b
c
c
1571between Ang-2 and VWF levels. First, the synthesis and
subsequent storage of Ang-2 and VWF in de Weibel-Pa-
lade bodies may become differently regulated throughout
the course of disease, so that the ratio between Ang-2 and
VWF changed. Second, Ang-2 may not only be released
from the Weibel-Palade body, but also by constitutive
secretion from the cytoplasm. Indeed, Ang-2 is uniformly
distributed in the cytoplasm of endothelial cells in the
absence of VWF [13]. Third, the binding or consumption
of VWF may be increased in more severely ill patients, for
example, during diffuse intravascular coagulation.
Our study has several limitations. First, the relation
between Ang-2 and a positive ﬂuid balance or pulmonary
dysfunction was relatively modest (r = 0.25–0.30),
suggesting that the positive ﬂuid balance and pulmonary
dysfunction are only partly due to increased Ang-2 levels.
Indeed, it has been reported that Ang-2 sensitizes the
endothelium to inﬂammatory stimuli rather than acting
alone in the vascular system [37]. Second, it was not fea-
sible to measure the pulmonary vascular permeability in a
more direct manner with the pulmonary leak index method
aswedidinourpreviousstudy[12].Instead,westudiedthe
relationwithﬂuidbalanceassurrogateindicatorofvascular
permeability.Thedatasuggestthatdifferencesandchanges
in ﬂuid balance were not confounded by differences and
changes in renal function as can be judged, albeit imper-
fectly, from serum creatinine levels. Therefore, changes in
the ﬂuid balance are likely explained, at least in part, by
a
b
c
Fig. 2 Angiopoietin and VWF levels on day 0 and the last ICU day
in survivors and non-survivors. Individual levels and box plot of a
circulating angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor
(VWF; % of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml)
on day 0 and the last intensive care unit (ICU) day in ICU survivors
and ICU non-survivors. Values in boxes are at 25th percentile,
median and 75th percentile; whiskers are 10th and 90th percentile. a
Ang-2 levels decreased from day 0 to the last ICU day in survivors
(*P = 0.0033, n = 35 pairs), while they did not change in non-
survivors (P = 0.3910, n = 15 pairs). Data not shown: Day 0
survivor: 25,090 pg/ml; day 0 non-survivor: 17,980 and 125,100 pg/
ml; last ICU day non-survivor: 12,050 and 116,800 pg/ml; 90th
percentile of non-survivors day 0: 60,828 pg/ml; 90th percentile of
non-survivors last ICU day: 53,950 pg/ml. b VWF levels increased
from day 0 to the last ICU day in survivors (*P = 0.0057, n = 35
pairs) and did not change in non-survivors (P = 0.5070, n = 14
pairs). c Ang-1 levels did not differ between day 0 and the last ICU
day in survivors (P = 0.1044, n = 35 pairs) or non-survivors
(P = 0.7612, n = 14 pairs)
1572changes in vascular permeability, even though not reﬂect-
ing pulmonary vascular permeability directly. However, it
is likely that the systemic and pulmonary vascular endo-
thelium are simultaneously activated, since both are
exposed to circulating inﬂammatory mediators. Further-
more, the ﬂuid balance related to the PaO2/FiO2 ratio and
the oxygenation index, and we conﬁrmed that a positive
ﬂuidbalanceisrelatedtoaworseoutcomeinALIandseptic
shock [26, 27], suggesting that a positive ﬂuid balance
includes pulmonary injury-induced oedema. Third, the
plasmalevelsofAng-2,VWFandAng-1andthedifference
in Ang-2 levels between survivors and non-survivors may
have been underestimated due to ﬂuid resuscitation and
plasmadilution.Thisindicatesthatthedifferenceinplasma
levelsofthemeasuredproteinsmaybeevengreaterandthe
relation with the ﬂuid balance and pulmonary dysfunction
evenstronger.Fourth,inmultivariateanalysis,APACHEII
score and Ang-2, but not ﬂuid balance, PaO2/FiO2 ratio,
oxygenation index, PEEP and Ang-1 at day 0 remained
signiﬁcantly predictive factors of ICU mortality. Never-
theless,thevalueof thisanalysisis limitedin ourrelatively
small group of 50 patients.
In conclusion, in contrast to VWF levels, increased
Ang-2 levels relate to a positive ﬂuid balance and pul-
monary dysfunction throughout the course of septic shock.
While VWF levels only predict ICU mortality early in
the course of septic shock, Ang-2 levels do so throughout
the course. Pharmacological blockade of Ang-2 during the
course of septic shock might reduce the degree of vascular
permeability and pulmonary dysfunction and should be
pursued in future studies for outcome beneﬁts.
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